Is JAK effective in treating recurrent SAPHO syndrome? TwHF might be a good choice

Author:

Sun Qiong12,Gu Qinchen12,Jiang Haixu3,Li Weizhong4,Lin Zhimin5,Li Chen4,Ying Zhenhua267ORCID

Affiliation:

1. The Second College of Clinical Medicine, Zhejiang Chinese Medical University, Zhejiang 310014, China

2. Department of Rheumatology and Immunology, Center for General Practice Medicine, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Zhejiang 310014, China

3. School of Chinese Materia, Beijing University of Chinese Medicine, Beijing 102488, China

4. Department of Rheumatology, Fangshan Hospital, Beijing University of Chinese Medicine, Beijing 102401, China

5. Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing 100700, China

6. Institute of Rheumatology and Immunology, Hangzhou Medical College, Zhejiang 310014, China

7. Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Cultivation for Arthritis Diagnosis and Treatment, Zhejiang 310014, China

Abstract

Background: Recently, JAKi has also been widely proved to be an effective alternative to conventional treatment for Synovitis acne pustulosis–hyperostosis–osteitis (SAPHO) cases, after failure of multiple drugs including those described above. But what to do when all these treatments fail? We report a case of remission from Tripterygium wilfordii Hook (TwHF) treatment. Methods: The patient was treated with nonsteroidal anti-inflammatory drugs, oral prednisone, minocycline, bisphosphonate injection, etanercept, and tofacitinib, but the symptoms did not change significantly. Treatment with TwHF (1.0 mg/kg/day, patient weight 60 kg) was started for 24 weeks. Results: After 50 months of unsatisfactory treatment, this patient was finally treated with herbal TwHF, and after 6 months of treatment, the patient’s magnetic resonance imaging and inflammatory indexes were significantly improved, indicating that the disease had been better controlled. Conclusion: In this study, TwHF was successful in treating a patient with refractory SAPHO syndrome who was refractory to multiple Western medications without significant adverse effects or toxicities, but further follow-up is needed to determine long-term efficacy. More case reports as well as clinical trials are still needed to confirm whether TwHF can effectively treat refractory SAPHO syndrome.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3